The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts.
Breistøl, K
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts. [electronic resource] - European journal of cancer (Oxford, England : 1990) Sep 1998 - 1602-6 p. digital
Publication Type: Journal Article
0959-8049
10.1016/s0959-8049(98)00152-x doi
Animals
Antineoplastic Agents--therapeutic use
Breast Neoplasms--drug therapy
Carcinoma, Non-Small-Cell Lung--drug therapy
Carcinoma, Small Cell--drug therapy
Cell Division--drug effects
Dose-Response Relationship, Drug
Doxorubicin--analogs & derivatives
Female
Humans
Lung Neoplasms--drug therapy
Mice
Mice, Inbred BALB C
Prodrugs--therapeutic use
Transplantation, Heterologous
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts. [electronic resource] - European journal of cancer (Oxford, England : 1990) Sep 1998 - 1602-6 p. digital
Publication Type: Journal Article
0959-8049
10.1016/s0959-8049(98)00152-x doi
Animals
Antineoplastic Agents--therapeutic use
Breast Neoplasms--drug therapy
Carcinoma, Non-Small-Cell Lung--drug therapy
Carcinoma, Small Cell--drug therapy
Cell Division--drug effects
Dose-Response Relationship, Drug
Doxorubicin--analogs & derivatives
Female
Humans
Lung Neoplasms--drug therapy
Mice
Mice, Inbred BALB C
Prodrugs--therapeutic use
Transplantation, Heterologous